PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.75 0.00 (-0.29%)
As of: Oct 2, 2026 · 9:32 AM EDT

PMV Pharmaceuticals (PMVP) Liabilities and Shareholders Equity (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) recorded Liabilities and Shareholders Equity of $82.07 million in Q2 2026, down 46.3% from $152.86 million a year earlier and down 15.0% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, PMV Pharmaceuticals reported Liabilities and Shareholders Equity of $116.56 million, down 39.1% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for five straight years, with a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $191.29 million in FY2024 (-24.1%), $252.15 million in FY2023 (-6.7%), $270.31 million in FY2022 (-18.5%) and $331.57 million in FY2021 (-9.3%).
  • The Q2 2026 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2019.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for 20 consecutive quarters, with an average decline of 33.9% over the last eight quarters.
  • Across the past five years, year-over-year decline in Liabilities and Shareholders Equity ran from 1.9% in Q2 2024 to 46.3% in Q2 2026.
  • Per Business Quant, the preceding three quarters came in at $96.56 million (Q1 2026), $116.56 million (Q4 2025) and $133.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 PMV Pharmaceuticals 89.28 Mn -325.89 Mn - 82.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82.07 Mn
Mar 31, 2026 96.56 Mn
Dec 31, 2025 116.56 Mn
Sep 30, 2025 133.84 Mn
Jun 30, 2025 152.86 Mn
Mar 31, 2025 170.61 Mn
Dec 31, 2024 191.29 Mn
Sep 30, 2024 223.50 Mn
Jun 30, 2024 237.54 Mn
Mar 31, 2024 236.88 Mn
Dec 31, 2023 252.15 Mn
Sep 30, 2023 261.03 Mn
Jun 30, 2023 242.22 Mn
Mar 31, 2023 253.96 Mn
Dec 31, 2022 270.31 Mn
Sep 30, 2022 284.98 Mn
Jun 30, 2022 300.56 Mn
Mar 31, 2022 315.01 Mn
Dec 31, 2021 331.57 Mn
Sep 30, 2021 344.18 Mn
API Access

PMV Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PMVP&period=max&api_key=YOUR_API_KEY